Europlasma S.A.
ALEUP.PA · PAR
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Revenue | €26,890 | €15,561 | €8,238 | €7,168 |
| % Growth | 72.8% | 88.9% | 14.9% | – |
| Cost of Goods Sold | €38,879 | €24,733 | €18,332 | €13,666 |
| Gross Profit | -€11,989 | -€9,172 | -€10,094 | -€6,498 |
| % Margin | -44.6% | -58.9% | -122.5% | -90.7% |
| R&D Expenses | €0 | €0 | €0 | €0 |
| G&A Expenses | €0 | €0 | €0 | €0 |
| SG&A Expenses | €3,351 | €1,409 | €972 | €1,906 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | €213 | €431 | €214 | €155 |
| Operating Expenses | €3,564 | €1,840 | €1,186 | €2,061 |
| Operating Income | -€15,553 | -€11,012 | -€11,280 | -€8,559 |
| % Margin | -57.8% | -70.8% | -136.9% | -119.4% |
| Other Income/Exp. Net | -€4,905 | €12,807 | -€864 | €5,603 |
| Pre-Tax Income | -€20,458 | €1,795 | -€12,144 | -€2,956 |
| Tax Expense | -€2,429 | -€325 | €83 | -€438 |
| Net Income | -€17,411 | €2,120 | -€12,226 | -€2,518 |
| % Margin | -64.7% | 13.6% | -148.4% | -35.1% |
| EPS | -0.95 | 0.94 | -200.65 | -1,476 |
| % Growth | -201.1% | 100.5% | 86.4% | – |
| EPS Diluted | -0.95 | 0.23 | -200.65 | -1,476 |
| Weighted Avg Shares Out | 18,323 | 2,267 | 61 | 2 |
| Weighted Avg Shares Out Dil | 18,323 | 9,408 | 61 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | €3 | €11 | €30 | €10 |
| Interest Expense | €686 | €2,461 | €2,873 | €708 |
| Depreciation & Amortization | €10,155 | €2,573 | €4,834 | €2,024 |
| EBITDA | -€9,617 | €6,829 | -€4,437 | -€224 |
| % Margin | -35.8% | 43.9% | -53.9% | -3.1% |